Dr. Klaus Kleinfeld and Dr. Karl Biesinger Elected to the SNP Board of Directors with an Overwhelming Majority of Votes

Leonie Steegmüller
| 1 min read
  • Shareholders vote for new authorized capital of up to around EUR 3.3 million
  • Excellent order situation underscores expectations for strong sales and earnings in the second half of the year 2019

Heidelberg, Germany, June 7, 2019 - With an overwhelming majority of votes, the Annual General Meeting of Schneider-Neureither & Partner SE has ratified the by-elections to the Board of Directors and elected Dr. Klaus Kleinfeld and Dr. Karl Biesinger as new members of the board. The Annual General Meeting, held on June 6, 2019, also agreed to all other proposed resolutions and discharged the Managing Directors and the members of the Board of Directors. Following the Annual General Meeting, Dr. Klaus Kleinfeld was appointed Deputy Chairman.

Among other things, the shareholders voted in favor of the creation of new authorized capital totaling up to EUR 3,301,223. The corresponding agenda item was approved with 78-percent support. Authorization was granted for the legally valid period of five years.

The background is that the last authorized capital increases, from 2015 and 2017, were used primarily to finance growth. With this new authorized capital, the company aims to ensure that it will further be able to flexibly adjust its equity base at any time in the future in keeping with requirements and opportunities that arise, and thus continue to be able to finance both organic and inorganic growth.

Due to the excellent order situation in this year to date, management expects strong sales and earnings in the second half of 2019.

The presentation of the Annual General Meeting, the detailed voting results, and other documents pertaining to the Annual General Meeting are available at http://www.snpgroup.com/en/annual-general-meeting.